InvestorsHub Logo
Followers 20
Posts 5392
Boards Moderated 0
Alias Born 01/04/2012

Re: silvr_surfr post# 14972

Monday, 07/01/2024 12:02:53 PM

Monday, July 01, 2024 12:02:53 PM

Post# of 14983
I believe so, Silvr.

I checked out the authorized shares for US Pharmas with a market cap exceeding $1 billion.

ANIP had the lowest at 33.33 million shares followed by :

LGND had 60 million shares
PTGX had 90 million shares

The rest had authorized 100 million shares or more.

As it stands ANIP will not be splitting their stock as it gets more expensive.
It is unlikely that they will use equity in any future deal unless the share price climbs considerably.
Another reverse split could be used down the road to free shares for a deal. This would make ANIP shares even pricier and out of reach for most retail investors.
If ALIM deal generates returns as expected and the CGON and Libigel royalties kick in, I expect they will be flush with cash and will not require much in the way of equity financing to fund growth.

Personnally, I hope the goal is not to sell ANIP, but to create a company that eventually pays high dividends.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News